Mapping large numbers of results may take a few moments.
Search Results
Showing 401 - 450 of 489 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company SiNON Nano Sciences Inc. | Activity: Research and Development | Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). | Location Durham |
| |
Company Sipcam Agro USA Inc. | Activity: Research and Development | Company Description SipcamAdvan develops and manufactures herbicides, pesticides, fungicides and biocides. | Location Durham |
| |
Company Sirtsei Pharmaceuticals Inc. | Activity: Research and Development | Company Description Sirtsei Pharmaceuticals is developing a product for depression and schizophrenia. | Location Morrisville |
| |
Company Sloan Biologics LLC | Activity: Research and Development | Company Description Sloan Biologics is developing therapies to enhance the health of farms and the communities that support them. | Location Statesville |
| |
Company Smithfield Premium Genetics Group | Activity: Research and Development | Company Description Smithfield Premium Genetics is focused on improving the genetic traits of hogs through the science of genomics. | Location Roanoke Rapids |
| |
Company SNP Therapeutics LLC | Activity: Research and Development | Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. | Location Kannapolis |
| |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham |
| |
Company Soil Health Institute | Activity: Research and Development | Company Description The Soil Health Institute partners with stakeholders to safeguard and enhance the vitality and productivity of soil through scientific research and advancement. | Location Morrisville |
| |
Company Solve Therapeutics Inc. | Activity: Research and Development | Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. | Location Durham |
| |
Company Sonokine Bioscience Inc. | Activity: Research and Development | Company Description Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies. | Location Chapel Hill |
| |
Company SonoVascular Inc. | Activity: Research and Development | Company Description SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to more effectively treat deep vein thrombosis and pulmonary embolism. | Location Chapel Hill |
| |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte |
| |
Company SP Innovations LLC | Activity: Research and Development | Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. | Location Raleigh |
| |
Company Sparta Biomedical Inc. | Activity: Research and Development | Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. | Location Morrisville |
| |
Company Speedwell Bio LLC | Activity: Research and Development | Company Description Speedwell Bio develops novel molecular assays and reagents for research and clinical diagnostics. | Location Chapel Hill |
| |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham |
| |
Company SPV Therapeutics Inc. | Activity: Research and Development | Company Description SPV Therapeutics is developing small molecule therapeutics to treat cancer. | Location Research Triangle Park |
| |
Company Standard Process Inc. | Activity: Research and Development | Company Description Standard Process develops supplements for veterinary and human use. The Standard Process Center of Excellence focuses on innovation in whole food-based nutritional therapy. | Location Kannapolis |
| |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary |
| |
Company Surgilūm LLC | Activity: Research and Development | Company Description Surgilūm designs, manufactures and markets medical instruments for use in cataract and refractive surgery. | Location Wilmington |
| |
Company Sustainable Agriculture Labs | Activity: Research and Development | Company Description Sustainable Agriculture Labs develops specialty crops via plant biotechnology methods. | Location Raleigh |
| |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. | Location Durham |
| |
Company Syngenta Crop Protection LLC (Greensboro) | Activity: Research and Development | Company Description Syngenta works to increase plant yield by developing products for disease, insect and weed control and drought tolerance. The Greensboro site is the North America Crop Protection Headquarters and performs crop protection product development. | Location Greensboro |
| |
Company Syngenta Crop Protection LLC (RTP) | Activity: Research and Development | Company Description Syngenta works to increase plant yield by developing products for disease, insect and weed control and drought tolerance. The Innovation Center in Research Triangle Park is the company's seeds center of excellence and includes the Advanced Crop Lab. | Location Research Triangle Park |
| |
Company Synoxa Sciences Inc. | Activity: Research and Development | Company Description Synoxa Sciences develops small molecule therapeutics to treat multi-drug resistant (MDR) bacterial pathogens, including those in the biofilm state. | Location Raleigh |
| |
Company SynShark LLC | Activity: Research and Development | Company Description SynShark is developing a method for extracting squalene from tobacco. Squalene is a specialty chemical typically derived from shark livers used for vaccines and cosmetics. | Location Leland |
| |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park |
| |
Company TARGAN Inc. | Activity: Research and Development | Company Description TARGAN is developing automated bio-system solutions for detecting, targeting, and delivering vaccines for the animal health industry. TARGAN's technologies aim to reduce the need for antibiotics by improving vaccination delivery. | Location Raleigh |
| |
Company Tavros Therapeutics Inc. | Activity: Research and Development | Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. | Location Research Triangle Park |
| |
Company TCRCure Biopharma Corp. | Activity: Research and Development | Company Description TCRCure Biopharma discovers and develops novel therapeutic targets in the field of cancer immunotherapy. | Location Durham |
| |
Company Techverse Inc. | Activity: Research and Development | Company Description Techverse provides contract chemistry and engineering R&D services for advanced energy technologies. Expertise includes membrane technologies for biotechnology applications; algae separation; and hydrogen generation, separation, storage and fuel cells. | Location Cary |
| |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park |
| |
Company Ten63 Therapeutics Inc. | Activity: Research and Development | Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. | Location Durham |
| |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville |
| |
Company TEO Systems Inc. | Activity: Research and Development | Company Description TEO Systems develops and sells optical and electronic devices and systems, including a label-free flow cytometer instrument for rapid analysis of biological cells and small particles. | Location Greenville |
| |
Company TerMir Inc. | Activity: Research and Development | Company Description TerMir is developing an antibacterial agent to treat citrus greening disease in citrus as well as bacterial diseases of perennial and annual crops. The products can be applied via irrigation, foliar spray or trunk injection treatment. | Location Raleigh |
| |
Company Ternalys Therapeutics Inc. | Activity: Research and Development | Company Description Ternalys develops technology that facilitates microRNA replacement therapy to treat glioblastoma and other cancers. | Location Chapel Hill |
| |
Company TerraStar Energy | Activity: Research and Development | Company Description TerraStar Energy provides turn-key systems to reduce waste and convert it to biogas, electricity, liquid fuels and solid and liquid fertilizers. Systems include anaerobic digestion, gasification, pyrolysis and boilers. | Location Lumberton |
| |
Company Tersus Environmental LLC | Activity: Research and Development | Company Description Tersus Environmental develops and markets technologies for the remediation of soil and groundwater. Services include aerobic bioremediation, bioaugmentation and cometabolic bioremediation. | Location Wake Forest |
| |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville |
| |
Company TheraBionic Inc. | Activity: Research and Development | Company Description TheraBionic is developing treatment approaches for cancer based on the use of tumor-specific modulation frequencies, with an initial focus in hepatocellular carcinoma. | Location Winston-Salem |
| |
Company TheraSplice | Activity: Research and Development | Company Description TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials. | Location Chapel Hill |
| |
Company TheraVida Inc. | Activity: Research and Development | Company Description TheraVida is developing a treatment for primary focal hyperhidrosis. | Location Chapel Hill |
| |
Company Tiamat Sciences Corp. | Activity: Research and Development | Company Description Tiamat Sciences Corp. produces plant-based recombinant proteins for cell culture and therapeutic applications. | Location Durham |
| |
Company Torque Bio Inc. | Activity: Research and Development | Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. | Location Durham |
| |
Company Traitology | Activity: Research and Development | Company Description Traitology uses computational biology, combined with new breeding technologies, to develops plant traits that improve yields, extend growing seasons, and make crops more resilient to climate change and disease. | Location Research Triangle Park |
| |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary |
| |
Company TransChromix LLC | Activity: Research and Development | Company Description TransChromix is developing novel therapeutic inventions for chronic inflammation-associated diseases, such as Type 1 diabetes and Alzheimer's disease. | Location Chapel Hill |
| |
Company TreeCo | Activity: Research and Development | Company Description TreeCo is using CRISPR technology, combining tree genetics with genome editing, to enhance trees for the forestry industry and the environment. | Location Raleigh |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |